Home » Topics » BioWorld Science

BioWorld Science
RSS

Researchers develop PXDN-mutant microphthalmia and dysgenesis murine model

May 15, 2018

FDA accepts for review BLA for pegfilgrastim biosimilar CHS-1701

May 15, 2018

Soleno Therapeutics initiates phase III study of DCCR in Prader-Willi syndrome

May 15, 2018

Lymph-directed compound ST-182 simultaneously inhibits MAPK, PI3K and mTOR

May 15, 2018

Galectin proceeds with plans for phase III program with GR-MD-02 in NASH cirrhosis

May 15, 2018

New ELMO3 gene mutation tied to keratoconus

May 15, 2018

Researchers at Ben-Gurion University develop a novel molecule for the treatment of cancer

May 15, 2018

Search for small-molecule PD-1/PD-L1 inhibitors yields JBI-426

May 15, 2018

FDA grants fast track designation to L1-79 for use in autism spectrum disorder

May 15, 2018

Concentric reports topline phase Ib data for CA-008 in postsurgical pain

May 15, 2018

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...